Addressing Challenges in the Management of Generalized Myasthenia Gravis in Specialized Populations: Considerations in Pregnancy and Pediatric Patients

This activity will be held during the AANEM Annual Meeting. It is not part of the official scientific program of AANEM.  Food will be provided by AANEM for this Industry Forum.

Thursday, October 17, 2024

11:30 AM – 11:45 AM: ET Registration/Lunch
11:45 AM – 12:45 PM: ET CE Symposium

Westin Savannah Harbor Golf Resort & Spa
1 Resort Drive
Savannah, GA 31421
Meeting Room: Grand Ballroom CDEF – Level 2

PROGRAM FEATURES

    • Interactive case-based presentation
    • Downloadable whiteboard animation
    • Online personalized poster generation portal

PROGRAM OVERVIEW

This satellite symposium will seek to increase healthcare provider’s ability to assess therapeutic developments for the management of myasthenia gravis (gMG), including the unique mechanism of FcRn antagonists; evaluate the burden of gMG in pregnant women, as well as current guidelines for care and challenges in management; and summarize best practices in the evaluation, guideline-informed treatment, and consideration of ongoing clinical trials in pediatric patients.

PRESENTING FACULTY

Professor of Clinical Neurology and PediatricsPerelman School of Medicine of the University of PennsylvaniaProgram Director of Neuromuscular Fellowship and EducationThe Children’s Hospital of PhiladelphiaPhiladelphia, PA

Alexis A. Lizarraga MD, MS
Associate Professor
Neuromuscular Division
Department of Neurology
University of Rochester School of Medicine & Dentistry
Rochester, NY
Sabrina W. Yum, MD
Professor of Clinical Neurology and Pediatrics
Perelman School of Medicine of the University of Pennsylvania
Program Director of Neuromuscular Fellowship and Education
The Children’s Hospital of Philadelphia
Philadelphia, PA

LEARNING OBJECTIVES:

  • Assess the therapeutic developments for the management of myasthenia gravis, including the unique mechanism of FcRn antagonists
  • Evaluate the burden of gMG in pregnant women, as well as current guidelines for care and challenges in management
  • Summarize best practices in the evaluation, guideline-informed treatment, and consideration of ongoing clinical trials in pediatric patients with gMG

TARGET AUDIENCE

This activity is designed to meet the educational needs of adult and pediatric neurologists and fellows; advanced care practitioners (eg, NPs, PharmD/RPh, and PAs); and other healthcare professionals who help manage people with gMG.

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in this live activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT 

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at [email protected]

Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

Healthcare Business Review Award

We are thrilled to announce that we have been recognized as one of the Top 10 Health Education Services Providers by Healthcare Business Review!

This award is both an honor and a testament to our cumulative dedication to providing the best continuing medical education (CME) services to HCPs across the globe. We are proud to be part of this distinguished group and look forward to continuing to have MLG be one of the best CME providers in the country.

Thank you to Healthcare Business Review for this recognition and for shining a light on the importance of accurate and accessible healthcare education.

#TopHealthEducationProvider #MedLearningGroup #HealthcareBusinessReview #MedicalEducation
BestofAmerica

Best of America Small Business Awards
Best Website

The Best of America Small Business Website award recognizes the best website launched by a small business since 2021. Technology is a key growth enabler for small businesses. The best in tech track recognizes small businesses as experts in technology and innovation from innovators, app developers, and website creators. Visit our award-winning Ophthalmology and Optometry web portal: vision-relief.com

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.